The study, led by Jennifer Severe, MD, and published in JMIR Formative Research, found that the convenience of receiving care without leaving home, avoiding exposure to COVID-19 and patients’ initial experience seeing a provider virtually contributed to patient preference to remain remote, according to a university blog post.
Anecdotal evidence suggests that remote healthcare also decreased no-show rates, possibly due to removing barriers like access to transportation or having to make arrangements for child care, according to the blog post.
The study seems to support a perspectives article Becker’s covered that suggests some patients may develop a preference for telehealth care in the long term. If a widespread demand for remote mental healthcare remains, it will be a factor for healthcare system leaders to continue addressing.
More articles on telehealth:
Viewpoint: How clinicians should address patient telehealth concerns fueled by the pandemic
FCC gets $250M to relaunch COVID-19 telehealth program, seeks public input
Physician viewpoint: 5 tips to help patients maximize telehealth benefits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
